头孢吡肟诱导神经毒性的易感因素:系统综述与荟萃分析
该系统综述与荟萃分析纳入23篇文章,旨在阐明头孢吡肟诱导神经毒性(CIN)的危险因素;eGFR<30 mL/min/1.73 m2是首要因素(OR=10.06,95%CI 5.05-20.03,P<0.0001),持续输注较间歇输注OR更低,并提出了TDM浓度阈值。
要点
- eGFR<30 mL/min/1.73 m2是CIN首要危险因素,OR=10.06(95%CI 5.05-20.03,P<0.0001)。
- 其他显著因素包括CNS异常、年龄、体重、白蛋白、糖尿病、高血压、慢性肺病及不适宜剂量。
- 间歇输注Ctrough阈值20 mg/L,持续输注Css阈值63 mg/L,持续输注OR更低。
核心结论
- 多种危险因素与CIN显著相关,其中肾功能损害最为显著。
- 持续输注头孢吡肟是除剂量调整和TDM外减轻CIN的潜在策略。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus、Web of Science和Google Scholar,关键词为cefepime和neurotoxicity。
- 共分析23篇文章,采用随机效应模型,二分类结局用Mantel-Haenszel法,连续结局用逆方差法。
主要发现
- eGFR<30 mL/min/1.73 m2是CIN首要因素,OR=10.06(95%CI 5.05-20.03,P<0.0001)。
- 其他显著因素包括CNS异常、年龄、体重、白蛋白水平、糖尿病、高血压、慢性肺病和不适宜剂量。
- 基于多个危险因素的持续输注亚组分析显示OR低于间歇输注。
关键数值与推荐
- 间歇输注头孢吡肟TDM的Ctrough阈值为20 mg/L。
- 持续输注头孢吡肟TDM的Css阈值为63 mg/L。
临床怎么用
- 对eGFR<30 mL/min/1.73 m2等高危患者应加强CIN监测。
- 可考虑持续输注头孢吡肟以降低CIN风险。
- 结合剂量调整与TDM(间歇输注Ctrough 20 mg/L,持续输注Css 63 mg/L)管理CIN风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to elucidate the risk factors associated with the development of cefepime-induced neurotoxicity (CIN). METHODS: This systematic review utilized keywords "cefepime" and "neurotoxicity", sourced from PubMed, Scopus, Web of Science and Google Scholar. Meta-analysis was conducted using a random effects model utilizing Mantel-Haenszel and inverse variance analysis for dichotomous and continuous outcomes, respectively. RESULTS: Analysis of 23 articles revealed that estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 is the primary factor in CIN, with an odds ratio of 10.06 (95% confidence interval [CI] = 5.05-20.03, P < 0.0001). Other significant factors include central nervous system (CNS) abnormalities, age, body weight, albumin levels, diabetes mellitus, hypertension, chronic lung disease and inappropriate dosing. Subgroup analysis of continuous cefepime infusion utilization, based on several risk factors, indicated a lower odds ratio in comparison to intermittent infusion. For cefepime therapeutic drug monitoring (TDM) to determine potential CIN cases, the proposed trough concentration (Ctrough) threshold for intermittent infusion is 20 mg/L, while the steady-state concentration (Css) threshold for continuous infusion is 63 mg/L. CONCLUSIONS: Numerous risk factors are significantly associated with CIN, with renal impairment being the most significant. Continuous cefepime infusion is a potential strategy to mitigate CIN, in addition to dose adjustment and TDM.
引用
- Hardi H, Louisa M, Widyahening IS, et al. Unveiling predisposing factors for cefepime-induced neurotoxicity: A systematic review and meta-analysis. Br J Clin Pharmacol. 2025. PMID: 40523836. doi:10.1002/bcp.70120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。